Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
1 selected
)
Type
Guidance (29)
Guidance programme
(
1 selected
)
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (7)
Clinical guidelines (234)
COVID-19 rapid guidelines (3)
Diagnostics guidance (52)
Health technology evaluations (18)
Highly specialised technologies guidance (29)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (353)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (766)
Apply filters
Showing 21 to 29 of 29
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Highly specialised technologies guidance
Remove Guidance programme: Highly specialised technologies guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2
HST12
27 November 2019
27 November 2019
Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutations
HST11
9 October 2019
9 October 2019
Patisiran for treating hereditary transthyretin amyloidosis
HST10
14 August 2019
14 August 2019
Inotersen for treating hereditary transthyretin amyloidosis
HST9
22 May 2019
22 May 2019
Burosumab for treating X-linked hypophosphataemia in children and young people
HST8
10 October 2018
10 October 2018
Strimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiency
HST7
7 February 2018
7 February 2018
Eliglustat for treating type 1 Gaucher disease
HST5
28 June 2017
28 June 2017
Migalastat for treating Fabry disease
HST4
22 February 2017
22 February 2017
Eculizumab for treating atypical haemolytic uraemic syndrome
HST1
28 January 2015
28 January 2015
Previous page
1
2
Current page
3
Page
3
of
3
Results per page
10
25
50
All
Back to top